Bolling Haygood
Baton Rouge, LANPI 1396731915
Payments from drug & device makers
$2,635in general payments, 2019–2025
Across 159 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$454
- GSK$373
- UCB, Inc.$241
- Johnson & Johnson$194
- Mallinckrodt Enterprises LLC$181
- Portola Pharmaceuticals, LLC$179
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,635100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 28 | $454 |
| GSK | 33 | $373 |
| UCB, Inc. | 12 | $241 |
| Johnson & Johnson | 12 | $194 |
| Mallinckrodt Enterprises LLC | 7 | $181 |
| Portola Pharmaceuticals, LLC | 9 | $179 |
| E.r. Squibb & Sons, L.L.C. | 11 | $163 |
| AstraZeneca | 8 | $101 |
| Merck | 6 | $99 |
| La Jolla Pharmaceutical Company | 6 | $92 |
| Paratek Pharmaceuticals, Inc. | 4 | $84 |
| Chiesi USA, Inc. | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Insmed, Inc. | 4 | $65 |
| Edwards Lifesciences | 1 | $41 |
| Astellas Pharma US Inc | 2 | $34 |
| Electromed, Inc. | 1 | $33 |
| Advanced Respiratory, Inc | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $22 |
| Livanova USA, Inc. | 1 | $20 |
| United Therapeutics Corporation | 1 | $18 |
| Cook Medical LLC | 1 | $16 |
| AbbVie | 1 | $14 |
| Pfizer | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.